Target intelligence / Profile preview

Solute carrier family 35 member F3 (SLC35F3)

Target
SLC35F3
Molecular classification
Transporter, Solute carrier family (SLC), subfamily 35, member F
01

Overview

Solute carrier family 35 member F3 (SLC35F3) is a membrane transporter protein that facilitates the intracellular transport of thiamine (vitamin B1) across cellular and possibly mitochondrial membranes[1][4][6]. It is encoded by the SLC35F3 gene, located on chromosome 1q42.2, and is predominantly expressed in adult cerebellum and other tissues[2][4]. SLC35F3 is classified as a member of the SLC35 family of solute carriers, specifically as a putative thiamine transporter, and plays a vital role in cellular thiamine homeostasis, which is essential for glucose metabolism and energy production[2][4]. Genetic variants in SLC35F3 have been associated with the regulation of blood pressure and the risk of hypertension, especially among certain populations[2][4][5]. The gene has also been linked to classical thiamine deficiency disorders (beriberi), due to its role in thiamine uptake[1][4]. SLC35F3 is not directly targeted by any approved therapeutics; however, thiamine acts as its physiological substrate. There are no major reported safety concerns for drug targeting of SLC35F3, but loss-of-function mutations may increase the risk of metabolic and cardiovascular diseases due to impaired thiamine transport.

Other names
FLJ37712Thiamine transporter SLC35F3Putative thiamine transporter SLC35F3SLC35F3phSLC35F3Q8IY50
02

Mechanism of action

Facilitates thiamine uptake into cells, including mitochondria, contributing to cellular energy metabolism

03

Biological functions

Thiamine (vitamin B1) transportIntracellular transport across membranes (cellular and mitochondrial)
04

Disease associations

HypertensionCardiovascular diseaseBeriberi (dry and wet types)
05

Safety considerations

No major drug safety concerns reported; potential risk in thiamine deficiency due to impaired transporter function
06

Interacting drugs

Thiamine (vitamin B1) (as a substrate, not a drug targeting SLC35F3 directly)
07

Biomarkers

Genetic polymorphisms (e.g., rs34032258, rs17514104, rs16842784) as risk markers for hypertension

Beyond the preview

Go deeper on Solute carrier family 35 member F3 (SLC35F3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Solute carrier family 35 member F3 (SLC35F3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call